Mikhail Blagosklonny is a researcher and scientists who has keen interests in the study of aging and cancer. His passion and interests began after he obtained his M.D in internal medicine. He went ahead to with his studies at the First Pavlov State Medical University of St Peterburg where he obtained a PhD in experimental medicine and also, cardiology.
Currently, Mikhail Blagosklonny is an oncology professor at the Rosewell Park Cancer Institute, an institution founded to help in the reduction of cancer challenges that patients face each day. Before that, Mikhail Blagosklonny worked at New York Medical College from 2002 to 2009, where he was the associate professor of medicine. He also worked at Ordway Research Institute as the senior scientist. His work experience, research and study in oncology and aging have given him an upper hand in the two fields.
Being a researcher, Mikhail Blagosklonny has used his determination in the formulation of his hypothesis on ResearchGate.net regarding the role played by TOR signaling in cancer and aging. Mikhail argues that by using rapamycin to cancer patients, they can increase their life expectancy with the drug. He is fully dedicated to his hypothesis and committed to prove his hypothesis right.
In addition to being a professor, Mikhail Blagosklonny is also an editor. He is a proficient and talented editor in chief of Aging, Oncotarget and Cell Cycle journals. Moreover, he also edits for the Cancer Biology and Therapy. His efforts and dedication have also been realized by the board of Cell Death and Differentiation where he is named as one of the editorial board members. He has several publications that he has edited and continues to gain more popularity from the works he has been involved in in science. See: http://www.nature.com/cdd/about/biographies.html
Mikhail Blagosklonny has made a name for himself in the publication sector. He has over two hundred and seventy published peer reviewed journals. He has gained so much credibility by being cited by other researchers and authors in the medical and scientific field. His continued involvement in research and oncology studies has made him an important scientist within the study of cancer and aging.